Flip - these are my exact notes (and my interpretation) regarding Flaskworks conversation with DI summarized below. This conversation happened in late December of last year so I do not know how things have changed, so do not hang DI or me for sharing this:
The most valuable information I learned about Flaskworks was that, they are already in the process of certifying flaskworks, it's efficacy in a dual-track style approach alongside the lab. As new vaccine samples are being created, they are executing the vaccine creation in side-by-side tracks. They are creating the vaccine in the lab setting, then also in the Flaskworks setting and comparing the quality side-by-side. He cautiously expects end of Q1/early Q2 for certification of Flaskworks production.